Director's name changed from Dr Neeti Madan Kapre to Dr Neeti Gupta
Sandu Pharmaceuticals has told the exchanges that Dr Neeti Madan Kapre, a Non Executive Independent Director, has changed her name to Dr Neeti Gupta after her marriage.
- DIN
- 06801264
- Name Change
- Dr Neeti Madan Kapre changed to Dr Neeti Gupta
- Designation Unchanged
- Non Executive Independent Director; designation, directorship and DIN unchanged
What the company has informed the exchange
- The name of Dr Neeti Madan Kapre (DIN: 06801264), a Non Executive Independent Director of the company, has been changed to Dr Neeti Gupta.
- The company states the change is consequent upon her marriage.
- The change is stated to be supported by the relevant documentary evidence and has been taken on record by the company.
- The company confirms there is no change in the designation, directorship or DIN of the director, and that this intimation is only in respect of the change in her name.
What the annexure sets out
- The director is named as Dr Neeti Gupta (DIN: 06801264).
- The reason recorded for the change is: change of name from Dr Neeti Madan Kapre (DIN: 06801264) to Dr Neeti Gupta.
- Against date of appointment or cessation and term of appointment, brief profile, disclosure of relationships between directors (in case of appointment of a director), and information required under the cited circulars, the entry is NA.
How to read this
A Director Identification Number, or DIN, is the permanent identity number a director holds with the Ministry of Corporate Affairs. It stays with the person even when the name changes. Because the DIN, the designation and the directorship are all unchanged, the same individual continues in the same role on the board.
The update is administrative in nature. It records a change in how the director is named in the company's records, supported by documentary evidence, and does not alter the composition of the board or the position she holds.
A disclosure of this kind is normally seen as a routine intimation, and it is useful mainly so that shareholders can match the new name to the same director and the same DIN in future updates and records.
Also from Sandu Pharmaceuticals
Reminder letters sent to physical shareholders to furnish PAN and KYC details
30 Sep 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.